Elevar Therapeutics Submits New Drug Application to FDA for Combination of Rivoceranib and Camrelizumab as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma
17 mai 2023 07h00 HE
|
Elevar Therapeutics
FORT LEE, N.J., May 17, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a wholly owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Cancer Immunotherapy Market to reach USD 261.7 Bn in 2031, expanding at a CAGR of 13.6%: TMR Report
11 mai 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, May 11, 2023 (GLOBE NEWSWIRE) -- The global cancer immunotherapy market is projected to flourish at a CAGR of 13.6% from 2022 to 2031. As per the report...
Mice Model Market to Reach USD 2.3 Bn Growing at a CAGR of 6.2% from 2021 to 2028 – Global Analysis by Transparency Market Research
02 mai 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, May 02, 2023 (GLOBE NEWSWIRE) -- The global mice model market stood at USD 1.5 billion in 2020 and the global market is projected to reach USD 2.3 billion by...
Elevar Therapeutics Presents AACR 2023 Poster Demonstrating Rivoceranib as Most Selective VEGFR-2 Inhibitor When Compared to Other TKIs With Known Activity Against VEGFR-2
18 avr. 2023 09h00 HE
|
Elevar Therapeutics
ORLANDO, Fla., April 18, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001
28 mars 2023 03h45 HE
|
AKAMPION
- Novel compound for targeted tumor therapy to be evaluated in patients with soft tissue sarcoma- First patients to be enrolled in Q2, 2023 Munich, Germany – March 28, 2023 – Thermosome, a...
Jowin, the Apple in Korea’s cancer treatment, expands their business globally
21 févr. 2023 06h06 HE
|
JOWIN
Korea's innovative venture company Jowin declares its expansion into the global cancer care market through the establishment of a global telemedicine platform.A telemedicine platform for overseas...
Pancreatic Cancer Treatment Market Exhibits 15.7% CAGR to Hit USD 6.85 Billion by 2029
20 févr. 2023 07h04 HE
|
Fortune Business Insights
Pune, India, Feb. 20, 2023 (GLOBE NEWSWIRE) -- The global pancreatic cancer treatment market size was worth USD 2.15 billion in 2021 and is slated to rise from USD 2.48 billion in 2022 to USD 6.85...
[Latest] Global Cold Plasma Market Size/Share Worth USD 4.56 Billion by 2030 at a 14.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
30 nov. 2022 09h30 HE
|
Custom Market Insights
Sandy, Utah, USA, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cold Plasma Market Size, Share, Growth Analysis Report By Regime (Low-Pressure...
Isotope Production System begins commercial production of cancer-fighting lutetium-177
24 oct. 2022 02h30 HE
|
Bruce Power
Tiverton, Ontario, Oct. 24, 2022 (GLOBE NEWSWIRE) -- An international collaboration between Bruce Power, Isogen (a Kinectrics and Framatome company) and ITM Isotope Technologies Munich SE (ITM),...
Global Bone Cancer Treatment Market to Reach $1.8 Billion by 2031: Says AMR
21 oct. 2022 08h51 HE
|
Allied Market Research
Portland, OR, Oct. 21, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Bone Cancer Treatment Market was estimated at $1.2 billion in 2021 and is...